Coronavirus vaccine: AstraZeneca says smaller dosing regime reaches 90% efficacy

AstraZeneca and the University of Oxford say their COVID-19 vaccine has an average efficacy of 70.4% after recording 131 coronavirus cases within its trial. One dosing regime regiments has shown a higher level of 90% according to the interim results. 

The more efficient dosing regime uses half a dose in the first inoculation rather than a full one. That means that more people could be vaccinated using the same amount of material. The 90% efficient regiment is of 1.5 doses rather than two. 

From the statement

One dosing regimen (n=2,741) showed vaccine efficacy of 90% when AZD1222 was given as a half dose, followed by a full dose at least one month apart...

Excitingly, we’ve found that one of our dosing regimens may be around 90% effective and if this dosing regime is used, more people could be vaccinated with planned vaccine supply

AstraZeneca's immunization can be stored at normal cooling temperatures. The firm is set to imminently prepare for emergency regulatory submission. Moderna announced an efficacy of 94.5% and the Pfizer/BioNTech project 95%. 

Matt Hancock, the UK's health minister, said that the vaccine is easier to administer and that Britain has 100 million doses in the pipeline. The EU also has a substantial amount of doses for its member states. 

Pound/dollar has been standing out in positively responding to immunization news. The currency pair is trading at the highest levels in two months, above 1.33. EUR/USD is also on the rise, changing hands closer to 1.19.

More When the market shivers, the Fed delivers? Where next for markets

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.

Feed news

Latest Forex News

Latest Forex News

Editors’ Picks

EUR/USD falls toward 1.19 after robust US Nonfarm Payrolls data

EUR/USD is trading above 1.19 after dipping below that number in response to the US Nonfarm Payrolls, which showed an increase of 379K jobs in February. Higher yields in response to Powell are keeping the dollar bid.


GBP/USD recovers after post-NFP dip below 1.38

GBP/USD is trading above 1.38 bus till down the day. The US gained 379.000 jobs, roughly double than expected and supporting the dollar. The Senate's stimulus debate is eyed.


XAU/USD battles 1700 level

Gold is staging a rebound toward $1,700 amid proift-taking ahead of the weekend but remains on track to close the third straight week in the negative territory.

Gold News

Ethereum price primed for a swift recovery as the network prepares for a major update in July

Ethereum price aims for a significant recovery towards $2,000. A major upgrade scheduled for July intends to fix the problem with gas fees on Ethereum. ETH miners are not happy with the decision.

Read more

US Dollar Index pushes higher to 92.20 on stellar Payrolls

The march north in the greenback remains unabated and trade in fresh 2021 highs beyond the 92.00 hurdle when tracked by the US Dollar Index (DXY).

US Dollar Index News